A peptide derived from European hedgehog cathelicidin (CathEE-2a) significantly reduced HSV-1 brain viral loads in mice by boosting type I interferon responses.
Reduced brain viral loadsCathEE-2a significantly lowered HSV-1 in the brains of infected mice while reducing tissue damage
What the researchers found
CathEE-2a displayed strong antiviral activity in vitro and significantly reduced HSV-1 brain viral loads in a mouse infection model through upregulation of type I interferons and downstream antiviral genes.
Why it matters
HSV-1 infects over 3.7 billion people globally. An immunomodulatory antiviral peptide that boosts natural defenses could complement existing antivirals and address drug-resistant strains.
How the study worked
Peptide design from hedgehog cathelicidin, in vitro antiviral testing against HSV-1, in vivo mouse HSV-1 infection model with brain viral load quantification and histopathological analysis.
What this study cannot tell us
Mouse model only. Specific dosing, pharmacokinetics, and toxicity profile not fully characterized. Only tested against HSV-1; activity against other herpesviruses unknown.
How to read the evidence
Preclinical study with both in vitro and in vivo validation, plus mechanistic characterization. Promising lead compound needing further development.
When this study was published
Published in 2025, introducing a novel animal-derived antiviral peptide candidate.
The bigger picture
This study highlights that antimicrobial peptides from unexpected animal sources can have powerful antiviral properties, and that immunomodulatory mechanisms (boosting interferons) may be as important as direct viral killing.
Questions still open
- Could CathEE-2a be developed as a treatment for HSV-1 encephalitis?
- Does CathEE-2a show activity against other herpesviruses (HSV-2, VZV, CMV)?
- What is the therapeutic window and optimal dosing regimen for CathEE-2a?
Common questions
Why study hedgehog skin for antiviral drugs?
How does this peptide fight herpes virus?
Read the original research
A hedgehog cathelicidin-derived peptide exhibits antiviral activity against herpes simplex virus type 1 infection.
Frontiers in microbiology, 17, 1770133
Citation
Deng, Enjie; Pei, Yaping; Yuan, Kun; Yang, Juan; Cao, Suncheng-Ai; Yang, Xinyan; Li, Guilan; Liang, Libin; Jin, Lin; Zhu, Tengyu. (2026). A hedgehog cathelicidin-derived peptide exhibits antiviral activity against herpes simplex virus type 1 infection.. Frontiers in microbiology, 17, 1770133. https://doi.org/10.3389/fmicb.2026.1770133